nodes	percent_of_prediction	percent_of_DWPC	metapath
Naratriptan—Stinging—Epirubicin—thyroid cancer	0.00277	0.00277	CcSEcCtD
Naratriptan—Fatigue—Vandetanib—thyroid cancer	0.00277	0.00277	CcSEcCtD
Naratriptan—Angiopathy—Sorafenib—thyroid cancer	0.00277	0.00277	CcSEcCtD
Naratriptan—Immune system disorder—Sorafenib—thyroid cancer	0.00276	0.00276	CcSEcCtD
Naratriptan—Constipation—Vandetanib—thyroid cancer	0.00275	0.00275	CcSEcCtD
Naratriptan—Pain—Vandetanib—thyroid cancer	0.00275	0.00275	CcSEcCtD
Naratriptan—Scotoma—Doxorubicin—thyroid cancer	0.00274	0.00274	CcSEcCtD
Naratriptan—Arrhythmia—Sorafenib—thyroid cancer	0.00273	0.00273	CcSEcCtD
Naratriptan—Alopecia—Sorafenib—thyroid cancer	0.0027	0.0027	CcSEcCtD
Naratriptan—Blood disorder—Epirubicin—thyroid cancer	0.00269	0.00269	CcSEcCtD
Naratriptan—Erythema—Sorafenib—thyroid cancer	0.00266	0.00266	CcSEcCtD
Naratriptan—Feeling hot—Doxorubicin—thyroid cancer	0.00265	0.00265	CcSEcCtD
Naratriptan—Hyperaesthesia—Doxorubicin—thyroid cancer	0.00265	0.00265	CcSEcCtD
Naratriptan—Stinging—Doxorubicin—thyroid cancer	0.00256	0.00256	CcSEcCtD
Naratriptan—Glycosuria—Doxorubicin—thyroid cancer	0.00256	0.00256	CcSEcCtD
Naratriptan—Muscle spasms—Sorafenib—thyroid cancer	0.00255	0.00255	CcSEcCtD
Naratriptan—Body temperature increased—Vandetanib—thyroid cancer	0.00254	0.00254	CcSEcCtD
Naratriptan—Blood disorder—Doxorubicin—thyroid cancer	0.00249	0.00249	CcSEcCtD
Naratriptan—Ventricular extrasystoles—Epirubicin—thyroid cancer	0.00249	0.00249	CcSEcCtD
Naratriptan—Anaemia—Sorafenib—thyroid cancer	0.00245	0.00245	CcSEcCtD
Naratriptan—Syncope—Sorafenib—thyroid cancer	0.00238	0.00238	CcSEcCtD
Naratriptan—Ulcer—Epirubicin—thyroid cancer	0.00237	0.00237	CcSEcCtD
Naratriptan—Bone pain—Epirubicin—thyroid cancer	0.00234	0.00234	CcSEcCtD
Naratriptan—Loss of consciousness—Sorafenib—thyroid cancer	0.00233	0.00233	CcSEcCtD
Naratriptan—Cough—Sorafenib—thyroid cancer	0.00232	0.00232	CcSEcCtD
Naratriptan—Inflammation—Epirubicin—thyroid cancer	0.00231	0.00231	CcSEcCtD
Naratriptan—Asthenia—Vandetanib—thyroid cancer	0.00231	0.00231	CcSEcCtD
Naratriptan—Ventricular extrasystoles—Doxorubicin—thyroid cancer	0.0023	0.0023	CcSEcCtD
Naratriptan—Coordination abnormal—Epirubicin—thyroid cancer	0.00229	0.00229	CcSEcCtD
Naratriptan—Pruritus—Vandetanib—thyroid cancer	0.00227	0.00227	CcSEcCtD
Naratriptan—Arthralgia—Sorafenib—thyroid cancer	0.00226	0.00226	CcSEcCtD
Naratriptan—Myalgia—Sorafenib—thyroid cancer	0.00226	0.00226	CcSEcCtD
Naratriptan—Ventricular tachycardia—Epirubicin—thyroid cancer	0.00225	0.00225	CcSEcCtD
Naratriptan—Vaginal inflammation—Epirubicin—thyroid cancer	0.00225	0.00225	CcSEcCtD
Naratriptan—Dry mouth—Sorafenib—thyroid cancer	0.00221	0.00221	CcSEcCtD
Naratriptan—Diarrhoea—Vandetanib—thyroid cancer	0.0022	0.0022	CcSEcCtD
Naratriptan—Ulcer—Doxorubicin—thyroid cancer	0.0022	0.0022	CcSEcCtD
Naratriptan—Cystitis noninfective—Epirubicin—thyroid cancer	0.00219	0.00219	CcSEcCtD
Naratriptan—Bone pain—Doxorubicin—thyroid cancer	0.00217	0.00217	CcSEcCtD
Naratriptan—Cystitis—Epirubicin—thyroid cancer	0.00217	0.00217	CcSEcCtD
Naratriptan—Anaphylactic shock—Sorafenib—thyroid cancer	0.00217	0.00217	CcSEcCtD
Naratriptan—Infection—Sorafenib—thyroid cancer	0.00215	0.00215	CcSEcCtD
Naratriptan—Inflammation—Doxorubicin—thyroid cancer	0.00214	0.00214	CcSEcCtD
Naratriptan—Shock—Sorafenib—thyroid cancer	0.00213	0.00213	CcSEcCtD
Naratriptan—Fluid retention—Epirubicin—thyroid cancer	0.00213	0.00213	CcSEcCtD
Naratriptan—Nervous system disorder—Sorafenib—thyroid cancer	0.00213	0.00213	CcSEcCtD
Naratriptan—Dizziness—Vandetanib—thyroid cancer	0.00212	0.00212	CcSEcCtD
Naratriptan—Thrombocytopenia—Sorafenib—thyroid cancer	0.00212	0.00212	CcSEcCtD
Naratriptan—Vaginal infection—Epirubicin—thyroid cancer	0.00212	0.00212	CcSEcCtD
Naratriptan—Coordination abnormal—Doxorubicin—thyroid cancer	0.00212	0.00212	CcSEcCtD
Naratriptan—Skin disorder—Sorafenib—thyroid cancer	0.00211	0.00211	CcSEcCtD
Naratriptan—Ventricular tachycardia—Doxorubicin—thyroid cancer	0.00208	0.00208	CcSEcCtD
Naratriptan—Vaginal inflammation—Doxorubicin—thyroid cancer	0.00208	0.00208	CcSEcCtD
Naratriptan—Dry eye—Epirubicin—thyroid cancer	0.00207	0.00207	CcSEcCtD
Naratriptan—Oesophagitis—Epirubicin—thyroid cancer	0.00205	0.00205	CcSEcCtD
Naratriptan—Vomiting—Vandetanib—thyroid cancer	0.00204	0.00204	CcSEcCtD
Naratriptan—Bladder pain—Epirubicin—thyroid cancer	0.00203	0.00203	CcSEcCtD
Naratriptan—Cystitis noninfective—Doxorubicin—thyroid cancer	0.00203	0.00203	CcSEcCtD
Naratriptan—Rash—Vandetanib—thyroid cancer	0.00203	0.00203	CcSEcCtD
Naratriptan—Dermatitis—Vandetanib—thyroid cancer	0.00202	0.00202	CcSEcCtD
Naratriptan—Headache—Vandetanib—thyroid cancer	0.00201	0.00201	CcSEcCtD
Naratriptan—Cystitis—Doxorubicin—thyroid cancer	0.00201	0.00201	CcSEcCtD
Naratriptan—Musculoskeletal discomfort—Sorafenib—thyroid cancer	0.00197	0.00197	CcSEcCtD
Naratriptan—Fluid retention—Doxorubicin—thyroid cancer	0.00197	0.00197	CcSEcCtD
Naratriptan—Vaginal infection—Doxorubicin—thyroid cancer	0.00196	0.00196	CcSEcCtD
Naratriptan—Dyspnoea—Sorafenib—thyroid cancer	0.00193	0.00193	CcSEcCtD
Naratriptan—Dry eye—Doxorubicin—thyroid cancer	0.00192	0.00192	CcSEcCtD
Naratriptan—Nausea—Vandetanib—thyroid cancer	0.00191	0.00191	CcSEcCtD
Naratriptan—Oesophagitis—Doxorubicin—thyroid cancer	0.0019	0.0019	CcSEcCtD
Naratriptan—Bladder pain—Doxorubicin—thyroid cancer	0.00188	0.00188	CcSEcCtD
Naratriptan—Gastrointestinal disorder—Sorafenib—thyroid cancer	0.00187	0.00187	CcSEcCtD
Naratriptan—Fatigue—Sorafenib—thyroid cancer	0.00187	0.00187	CcSEcCtD
Naratriptan—Photosensitivity—Epirubicin—thyroid cancer	0.00186	0.00186	CcSEcCtD
Naratriptan—Pain—Sorafenib—thyroid cancer	0.00185	0.00185	CcSEcCtD
Naratriptan—Constipation—Sorafenib—thyroid cancer	0.00185	0.00185	CcSEcCtD
Naratriptan—Vascular purpura—Epirubicin—thyroid cancer	0.00182	0.00182	CcSEcCtD
Naratriptan—Eye pain—Epirubicin—thyroid cancer	0.00181	0.00181	CcSEcCtD
Naratriptan—Urticaria—Sorafenib—thyroid cancer	0.00172	0.00172	CcSEcCtD
Naratriptan—Photosensitivity—Doxorubicin—thyroid cancer	0.00172	0.00172	CcSEcCtD
Naratriptan—Body temperature increased—Sorafenib—thyroid cancer	0.00171	0.00171	CcSEcCtD
Naratriptan—Purpura—Epirubicin—thyroid cancer	0.00169	0.00169	CcSEcCtD
Naratriptan—Vascular purpura—Doxorubicin—thyroid cancer	0.00169	0.00169	CcSEcCtD
Naratriptan—Anaphylactoid reaction—Epirubicin—thyroid cancer	0.00168	0.00168	CcSEcCtD
Naratriptan—Eye pain—Doxorubicin—thyroid cancer	0.00167	0.00167	CcSEcCtD
Naratriptan—Cerebrovascular accident—Epirubicin—thyroid cancer	0.00166	0.00166	CcSEcCtD
Naratriptan—Migraine—Epirubicin—thyroid cancer	0.0016	0.0016	CcSEcCtD
Naratriptan—Hypersensitivity—Sorafenib—thyroid cancer	0.0016	0.0016	CcSEcCtD
Naratriptan—Purpura—Doxorubicin—thyroid cancer	0.00156	0.00156	CcSEcCtD
Naratriptan—Anaphylactoid reaction—Doxorubicin—thyroid cancer	0.00156	0.00156	CcSEcCtD
Naratriptan—Asthenia—Sorafenib—thyroid cancer	0.00155	0.00155	CcSEcCtD
Naratriptan—Cerebrovascular accident—Doxorubicin—thyroid cancer	0.00154	0.00154	CcSEcCtD
Naratriptan—Pruritus—Sorafenib—thyroid cancer	0.00153	0.00153	CcSEcCtD
Naratriptan—Dehydration—Epirubicin—thyroid cancer	0.00152	0.00152	CcSEcCtD
Naratriptan—Liver function test abnormal—Epirubicin—thyroid cancer	0.0015	0.0015	CcSEcCtD
Naratriptan—Dry skin—Epirubicin—thyroid cancer	0.00149	0.00149	CcSEcCtD
Naratriptan—Migraine—Doxorubicin—thyroid cancer	0.00148	0.00148	CcSEcCtD
Naratriptan—Diarrhoea—Sorafenib—thyroid cancer	0.00148	0.00148	CcSEcCtD
Naratriptan—Gastritis—Epirubicin—thyroid cancer	0.00144	0.00144	CcSEcCtD
Naratriptan—Dizziness—Sorafenib—thyroid cancer	0.00143	0.00143	CcSEcCtD
Naratriptan—Asthma—Epirubicin—thyroid cancer	0.00141	0.00141	CcSEcCtD
Naratriptan—Dehydration—Doxorubicin—thyroid cancer	0.0014	0.0014	CcSEcCtD
Naratriptan—Liver function test abnormal—Doxorubicin—thyroid cancer	0.00139	0.00139	CcSEcCtD
Naratriptan—Dry skin—Doxorubicin—thyroid cancer	0.00138	0.00138	CcSEcCtD
Naratriptan—Vomiting—Sorafenib—thyroid cancer	0.00138	0.00138	CcSEcCtD
Naratriptan—Angina pectoris—Epirubicin—thyroid cancer	0.00137	0.00137	CcSEcCtD
Naratriptan—Rash—Sorafenib—thyroid cancer	0.00137	0.00137	CcSEcCtD
Naratriptan—Dermatitis—Sorafenib—thyroid cancer	0.00137	0.00137	CcSEcCtD
Naratriptan—Headache—Sorafenib—thyroid cancer	0.00136	0.00136	CcSEcCtD
Naratriptan—Bronchitis—Epirubicin—thyroid cancer	0.00135	0.00135	CcSEcCtD
Naratriptan—Gastritis—Doxorubicin—thyroid cancer	0.00133	0.00133	CcSEcCtD
Naratriptan—Asthma—Doxorubicin—thyroid cancer	0.0013	0.0013	CcSEcCtD
Naratriptan—Pollakiuria—Epirubicin—thyroid cancer	0.0013	0.0013	CcSEcCtD
Naratriptan—Nausea—Sorafenib—thyroid cancer	0.00129	0.00129	CcSEcCtD
Naratriptan—Photosensitivity reaction—Epirubicin—thyroid cancer	0.00129	0.00129	CcSEcCtD
Naratriptan—Hyperglycaemia—Epirubicin—thyroid cancer	0.00127	0.00127	CcSEcCtD
Naratriptan—Angina pectoris—Doxorubicin—thyroid cancer	0.00127	0.00127	CcSEcCtD
Naratriptan—Pneumonia—Epirubicin—thyroid cancer	0.00126	0.00126	CcSEcCtD
Naratriptan—Drowsiness—Epirubicin—thyroid cancer	0.00126	0.00126	CcSEcCtD
Naratriptan—Bronchitis—Doxorubicin—thyroid cancer	0.00125	0.00125	CcSEcCtD
Naratriptan—Neuropathy peripheral—Epirubicin—thyroid cancer	0.00123	0.00123	CcSEcCtD
Naratriptan—Sweating—Epirubicin—thyroid cancer	0.0012	0.0012	CcSEcCtD
Naratriptan—Pollakiuria—Doxorubicin—thyroid cancer	0.0012	0.0012	CcSEcCtD
Naratriptan—Photosensitivity reaction—Doxorubicin—thyroid cancer	0.00119	0.00119	CcSEcCtD
Naratriptan—Sinusitis—Epirubicin—thyroid cancer	0.00118	0.00118	CcSEcCtD
Naratriptan—Hyperglycaemia—Doxorubicin—thyroid cancer	0.00118	0.00118	CcSEcCtD
Naratriptan—Pneumonia—Doxorubicin—thyroid cancer	0.00117	0.00117	CcSEcCtD
Naratriptan—Drowsiness—Doxorubicin—thyroid cancer	0.00116	0.00116	CcSEcCtD
Naratriptan—Bradycardia—Epirubicin—thyroid cancer	0.00115	0.00115	CcSEcCtD
Naratriptan—Neuropathy peripheral—Doxorubicin—thyroid cancer	0.00114	0.00114	CcSEcCtD
Naratriptan—Haemoglobin—Epirubicin—thyroid cancer	0.00113	0.00113	CcSEcCtD
Naratriptan—Haemorrhage—Epirubicin—thyroid cancer	0.00113	0.00113	CcSEcCtD
Naratriptan—Hypoaesthesia—Epirubicin—thyroid cancer	0.00112	0.00112	CcSEcCtD
Naratriptan—Sweating—Doxorubicin—thyroid cancer	0.00111	0.00111	CcSEcCtD
Naratriptan—Sinusitis—Doxorubicin—thyroid cancer	0.00109	0.00109	CcSEcCtD
Naratriptan—Bradycardia—Doxorubicin—thyroid cancer	0.00106	0.00106	CcSEcCtD
Naratriptan—Tinnitus—Epirubicin—thyroid cancer	0.00105	0.00105	CcSEcCtD
Naratriptan—Haemoglobin—Doxorubicin—thyroid cancer	0.00105	0.00105	CcSEcCtD
Naratriptan—Cardiac disorder—Epirubicin—thyroid cancer	0.00105	0.00105	CcSEcCtD
Naratriptan—Haemorrhage—Doxorubicin—thyroid cancer	0.00104	0.00104	CcSEcCtD
Naratriptan—Hypoaesthesia—Doxorubicin—thyroid cancer	0.00104	0.00104	CcSEcCtD
Naratriptan—Angiopathy—Epirubicin—thyroid cancer	0.00102	0.00102	CcSEcCtD
Naratriptan—Immune system disorder—Epirubicin—thyroid cancer	0.00102	0.00102	CcSEcCtD
Naratriptan—Chills—Epirubicin—thyroid cancer	0.00101	0.00101	CcSEcCtD
Naratriptan—Arrhythmia—Epirubicin—thyroid cancer	0.00101	0.00101	CcSEcCtD
Naratriptan—Alopecia—Epirubicin—thyroid cancer	0.000996	0.000996	CcSEcCtD
Naratriptan—Erythema—Epirubicin—thyroid cancer	0.000981	0.000981	CcSEcCtD
Naratriptan—Tinnitus—Doxorubicin—thyroid cancer	0.000973	0.000973	CcSEcCtD
Naratriptan—Cardiac disorder—Doxorubicin—thyroid cancer	0.000968	0.000968	CcSEcCtD
Naratriptan—Angiopathy—Doxorubicin—thyroid cancer	0.000946	0.000946	CcSEcCtD
Naratriptan—Muscle spasms—Epirubicin—thyroid cancer	0.000944	0.000944	CcSEcCtD
Naratriptan—Immune system disorder—Doxorubicin—thyroid cancer	0.000942	0.000942	CcSEcCtD
Naratriptan—Chills—Doxorubicin—thyroid cancer	0.000936	0.000936	CcSEcCtD
Naratriptan—Arrhythmia—Doxorubicin—thyroid cancer	0.000932	0.000932	CcSEcCtD
Naratriptan—Vision blurred—Epirubicin—thyroid cancer	0.000925	0.000925	CcSEcCtD
Naratriptan—Alopecia—Doxorubicin—thyroid cancer	0.000922	0.000922	CcSEcCtD
Naratriptan—Ill-defined disorder—Epirubicin—thyroid cancer	0.000911	0.000911	CcSEcCtD
Naratriptan—Erythema—Doxorubicin—thyroid cancer	0.000908	0.000908	CcSEcCtD
Naratriptan—Anaemia—Epirubicin—thyroid cancer	0.000907	0.000907	CcSEcCtD
Naratriptan—Agitation—Epirubicin—thyroid cancer	0.000902	0.000902	CcSEcCtD
Naratriptan—Malaise—Epirubicin—thyroid cancer	0.000885	0.000885	CcSEcCtD
Naratriptan—Vertigo—Epirubicin—thyroid cancer	0.000882	0.000882	CcSEcCtD
Naratriptan—Syncope—Epirubicin—thyroid cancer	0.00088	0.00088	CcSEcCtD
Naratriptan—Muscle spasms—Doxorubicin—thyroid cancer	0.000873	0.000873	CcSEcCtD
Naratriptan—Palpitations—Epirubicin—thyroid cancer	0.000867	0.000867	CcSEcCtD
Naratriptan—Loss of consciousness—Epirubicin—thyroid cancer	0.000863	0.000863	CcSEcCtD
Naratriptan—Cough—Epirubicin—thyroid cancer	0.000856	0.000856	CcSEcCtD
Naratriptan—Vision blurred—Doxorubicin—thyroid cancer	0.000856	0.000856	CcSEcCtD
Naratriptan—Convulsion—Epirubicin—thyroid cancer	0.00085	0.00085	CcSEcCtD
Naratriptan—Ill-defined disorder—Doxorubicin—thyroid cancer	0.000843	0.000843	CcSEcCtD
Naratriptan—Anaemia—Doxorubicin—thyroid cancer	0.000839	0.000839	CcSEcCtD
Naratriptan—Myalgia—Epirubicin—thyroid cancer	0.000836	0.000836	CcSEcCtD
Naratriptan—Arthralgia—Epirubicin—thyroid cancer	0.000836	0.000836	CcSEcCtD
Naratriptan—Agitation—Doxorubicin—thyroid cancer	0.000834	0.000834	CcSEcCtD
Naratriptan—Anxiety—Epirubicin—thyroid cancer	0.000833	0.000833	CcSEcCtD
Naratriptan—Discomfort—Epirubicin—thyroid cancer	0.000826	0.000826	CcSEcCtD
Naratriptan—Malaise—Doxorubicin—thyroid cancer	0.000819	0.000819	CcSEcCtD
Naratriptan—Dry mouth—Epirubicin—thyroid cancer	0.000817	0.000817	CcSEcCtD
Naratriptan—Vertigo—Doxorubicin—thyroid cancer	0.000816	0.000816	CcSEcCtD
Naratriptan—Syncope—Doxorubicin—thyroid cancer	0.000814	0.000814	CcSEcCtD
Naratriptan—Confusional state—Epirubicin—thyroid cancer	0.000808	0.000808	CcSEcCtD
Naratriptan—Palpitations—Doxorubicin—thyroid cancer	0.000802	0.000802	CcSEcCtD
Naratriptan—Oedema—Epirubicin—thyroid cancer	0.000801	0.000801	CcSEcCtD
Naratriptan—Anaphylactic shock—Epirubicin—thyroid cancer	0.000801	0.000801	CcSEcCtD
Naratriptan—Loss of consciousness—Doxorubicin—thyroid cancer	0.000798	0.000798	CcSEcCtD
Naratriptan—Infection—Epirubicin—thyroid cancer	0.000796	0.000796	CcSEcCtD
Naratriptan—Cough—Doxorubicin—thyroid cancer	0.000792	0.000792	CcSEcCtD
Naratriptan—Shock—Epirubicin—thyroid cancer	0.000788	0.000788	CcSEcCtD
Naratriptan—Convulsion—Doxorubicin—thyroid cancer	0.000787	0.000787	CcSEcCtD
Naratriptan—Nervous system disorder—Epirubicin—thyroid cancer	0.000785	0.000785	CcSEcCtD
Naratriptan—Thrombocytopenia—Epirubicin—thyroid cancer	0.000784	0.000784	CcSEcCtD
Naratriptan—Skin disorder—Epirubicin—thyroid cancer	0.000778	0.000778	CcSEcCtD
Naratriptan—Hyperhidrosis—Epirubicin—thyroid cancer	0.000774	0.000774	CcSEcCtD
Naratriptan—Myalgia—Doxorubicin—thyroid cancer	0.000773	0.000773	CcSEcCtD
Naratriptan—Arthralgia—Doxorubicin—thyroid cancer	0.000773	0.000773	CcSEcCtD
Naratriptan—Anxiety—Doxorubicin—thyroid cancer	0.00077	0.00077	CcSEcCtD
Naratriptan—Discomfort—Doxorubicin—thyroid cancer	0.000764	0.000764	CcSEcCtD
Naratriptan—Dry mouth—Doxorubicin—thyroid cancer	0.000756	0.000756	CcSEcCtD
Naratriptan—Hypotension—Epirubicin—thyroid cancer	0.000748	0.000748	CcSEcCtD
Naratriptan—Confusional state—Doxorubicin—thyroid cancer	0.000747	0.000747	CcSEcCtD
Naratriptan—Anaphylactic shock—Doxorubicin—thyroid cancer	0.000741	0.000741	CcSEcCtD
Naratriptan—Oedema—Doxorubicin—thyroid cancer	0.000741	0.000741	CcSEcCtD
Naratriptan—Infection—Doxorubicin—thyroid cancer	0.000736	0.000736	CcSEcCtD
Naratriptan—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.00073	0.00073	CcSEcCtD
Naratriptan—Shock—Doxorubicin—thyroid cancer	0.000729	0.000729	CcSEcCtD
Naratriptan—Nervous system disorder—Doxorubicin—thyroid cancer	0.000727	0.000727	CcSEcCtD
Naratriptan—Thrombocytopenia—Doxorubicin—thyroid cancer	0.000726	0.000726	CcSEcCtD
Naratriptan—Skin disorder—Doxorubicin—thyroid cancer	0.00072	0.00072	CcSEcCtD
Naratriptan—Paraesthesia—Epirubicin—thyroid cancer	0.000719	0.000719	CcSEcCtD
Naratriptan—Hyperhidrosis—Doxorubicin—thyroid cancer	0.000716	0.000716	CcSEcCtD
Naratriptan—Dyspnoea—Epirubicin—thyroid cancer	0.000714	0.000714	CcSEcCtD
Naratriptan—Somnolence—Epirubicin—thyroid cancer	0.000712	0.000712	CcSEcCtD
Naratriptan—Hypotension—Doxorubicin—thyroid cancer	0.000693	0.000693	CcSEcCtD
Naratriptan—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.000691	0.000691	CcSEcCtD
Naratriptan—Fatigue—Epirubicin—thyroid cancer	0.000691	0.000691	CcSEcCtD
Naratriptan—Constipation—Epirubicin—thyroid cancer	0.000685	0.000685	CcSEcCtD
Naratriptan—Pain—Epirubicin—thyroid cancer	0.000685	0.000685	CcSEcCtD
Naratriptan—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.000675	0.000675	CcSEcCtD
Naratriptan—Paraesthesia—Doxorubicin—thyroid cancer	0.000665	0.000665	CcSEcCtD
Naratriptan—Dyspnoea—Doxorubicin—thyroid cancer	0.000661	0.000661	CcSEcCtD
Naratriptan—Feeling abnormal—Epirubicin—thyroid cancer	0.00066	0.00066	CcSEcCtD
Naratriptan—Somnolence—Doxorubicin—thyroid cancer	0.000659	0.000659	CcSEcCtD
Naratriptan—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.00064	0.00064	CcSEcCtD
Naratriptan—Fatigue—Doxorubicin—thyroid cancer	0.000639	0.000639	CcSEcCtD
Naratriptan—Urticaria—Epirubicin—thyroid cancer	0.000636	0.000636	CcSEcCtD
Naratriptan—Constipation—Doxorubicin—thyroid cancer	0.000634	0.000634	CcSEcCtD
Naratriptan—Pain—Doxorubicin—thyroid cancer	0.000634	0.000634	CcSEcCtD
Naratriptan—Body temperature increased—Epirubicin—thyroid cancer	0.000633	0.000633	CcSEcCtD
Naratriptan—Feeling abnormal—Doxorubicin—thyroid cancer	0.000611	0.000611	CcSEcCtD
Naratriptan—Hypersensitivity—Epirubicin—thyroid cancer	0.00059	0.00059	CcSEcCtD
Naratriptan—Urticaria—Doxorubicin—thyroid cancer	0.000589	0.000589	CcSEcCtD
Naratriptan—Body temperature increased—Doxorubicin—thyroid cancer	0.000586	0.000586	CcSEcCtD
Naratriptan—Asthenia—Epirubicin—thyroid cancer	0.000575	0.000575	CcSEcCtD
Naratriptan—Pruritus—Epirubicin—thyroid cancer	0.000567	0.000567	CcSEcCtD
Naratriptan—Diarrhoea—Epirubicin—thyroid cancer	0.000548	0.000548	CcSEcCtD
Naratriptan—Hypersensitivity—Doxorubicin—thyroid cancer	0.000546	0.000546	CcSEcCtD
Naratriptan—Asthenia—Doxorubicin—thyroid cancer	0.000532	0.000532	CcSEcCtD
Naratriptan—Dizziness—Epirubicin—thyroid cancer	0.00053	0.00053	CcSEcCtD
Naratriptan—Pruritus—Doxorubicin—thyroid cancer	0.000524	0.000524	CcSEcCtD
Naratriptan—Vomiting—Epirubicin—thyroid cancer	0.000509	0.000509	CcSEcCtD
Naratriptan—Diarrhoea—Doxorubicin—thyroid cancer	0.000507	0.000507	CcSEcCtD
Naratriptan—Rash—Epirubicin—thyroid cancer	0.000505	0.000505	CcSEcCtD
Naratriptan—Dermatitis—Epirubicin—thyroid cancer	0.000505	0.000505	CcSEcCtD
Naratriptan—Headache—Epirubicin—thyroid cancer	0.000502	0.000502	CcSEcCtD
Naratriptan—Dizziness—Doxorubicin—thyroid cancer	0.00049	0.00049	CcSEcCtD
Naratriptan—Nausea—Epirubicin—thyroid cancer	0.000476	0.000476	CcSEcCtD
Naratriptan—Vomiting—Doxorubicin—thyroid cancer	0.000471	0.000471	CcSEcCtD
Naratriptan—Rash—Doxorubicin—thyroid cancer	0.000467	0.000467	CcSEcCtD
Naratriptan—Dermatitis—Doxorubicin—thyroid cancer	0.000467	0.000467	CcSEcCtD
Naratriptan—Headache—Doxorubicin—thyroid cancer	0.000464	0.000464	CcSEcCtD
Naratriptan—Nausea—Doxorubicin—thyroid cancer	0.00044	0.00044	CcSEcCtD
